Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
31 juli, 15:30
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
PR Newswire
SALT LAKE CITY, July 31, 2025
SALT LAKE CITY , July 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2025 financial results on Thursday, August 14, 2025 , after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan , Chief Executive Officer, Brian Brown , Chief Financial Officer, and Andrew Benson , Head of Investor Relations.
The conference call and webcast will be available via:
Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here
Conference Call: 888-880-3330 (Toll Free) or (646) 357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify genetic markers for use in applications other than infectious disease.
SOURCE Co-Diagnostics
Ämnen i artikeln
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
31 juli, 15:30
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
PR Newswire
SALT LAKE CITY, July 31, 2025
SALT LAKE CITY , July 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2025 financial results on Thursday, August 14, 2025 , after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan , Chief Executive Officer, Brian Brown , Chief Financial Officer, and Andrew Benson , Head of Investor Relations.
The conference call and webcast will be available via:
Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here
Conference Call: 888-880-3330 (Toll Free) or (646) 357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify genetic markers for use in applications other than infectious disease.
SOURCE Co-Diagnostics
Ämnen i artikeln
Handelskrig
Apple
Analys
Handelskrig
Mest läst
Apple
Analys
Senaste nytt
Handelskrig
1 augusti, 15:51
Professorn: "Svårt att tänka sig en guldålder"
Kempower
1 augusti, 12:28
Laddat för tillväxt i Kempower
Novo Nordisk
1 augusti, 10:47
1000 miljarder utraderade i Novo Nordisk
Marknadsöversikt
OMX Stockholm 30
1 DAG %
−1,80%
Senast
2 533,59
1 mån
Loading market data...
Privatekonomi med Placeras expert
Affärsvärlden
